Celyad Oncology SA

EBR:CYAD.BR

0.25 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 7.0044.97612.44514.38520.51230.0186.09812.01712.13317.23426.69239.33833.66840.54262.38523.25323.44948.35753.693100.175116.11827.63335.07119.0583.9431.645
Short Term Investments 00000000000009.1970.84310.65345.38634.2332.3387.3387.6712.6715300
Cash and Short Term Investments 7.0044.97612.44514.38520.51230.0186.09812.01712.13317.23426.69239.33833.66849.73963.22833.90668.83582.58786.031107.513123.78930.30440.07122.0583.9431.645
Net Receivables 2.782.0961.2593.7163.3462.343.9072.9351.4060.9072.1232.7020.3981.2690.2711.5921.3181.5031.3671.0750.7331.7170.1250.4210.3030.443
Inventory 000-3.250-2.1370001.563-1.672000.6830-1.35901.27800.83200.913000-1.645
Other Current Assets 1.3370.6221.1214.5292.234.0712.1641.6422.2940.0012.2960.7961.4090.0013.5042.2550.709-0.0010.926-0.0011.1410.0012.0450.1230.7481.749
Total Current Assets 11.1217.69414.82519.3826.08834.29212.16916.59415.83319.70529.43942.83635.47551.69267.00336.39470.86285.36788.324109.419125.66332.93542.24122.6024.9942.192
Non-Current Assets:
Property, Plant & Equipment, Net 1.830.8480.3092.8553.0083.2483.4193.5923.8074.1194.2315.0615.5253.0143.1483.293.0543.5633.6181.1360.6830.5980.4020.2430.290.383
Goodwill 0000.88300.88300.88300.8830.8830.8830.8830.8830.8830.9140.961.040.9891.003000000
Intangible Assets 0.0480.6450.45635.706035.285035.244035.28835.22335.31635.20435.28134.38335.59445.12748.52646.86947.78656.82310.2669.0639.49.5620
Goodwill and Intangible Assets 0.0480.6450.45636.58935.96736.16836.07436.12736.18136.17136.10636.19936.08736.16435.26636.50846.08749.56647.85848.78956.82310.2669.0639.49.56211.02
Long Term Investments 2.8042.78204.09402.20906.13705.7965.7535.4832.415000000000.0680000.151
Tax Assets -2.462-2.7820-4.0940-2.2090-6.1370-5.796-5.753-5.483-2.415000000000000-0.151
Other Non-Current Assets 2.9412.9914.1264.3164.1546.2356.5356.3756.286.0895.9845.744.2713.4293.641.4340.2920.3110.1930.180.1280.1090.0980.140.1990.151
Total Non-Current Assets 5.1614.4844.89143.7643.12945.65146.02846.09446.26846.37946.3214745.88342.60742.05441.23249.43353.4451.66950.10557.63411.0419.5639.78310.05111.554
Total Assets 16.28212.17819.71663.1469.21779.94358.19762.68862.10166.08475.7689.83681.35894.299109.05777.626120.295138.805139.993159.525183.29743.97651.80432.38615.04613.746
Liabilities & Equity:
Current Liabilities:
Account Payables 1.2433.4114.7526.0085.516.6115.6245.5824.5324.7365.7826.9695.4395.9166.4414.84.628.0985.6688.5766.3954.0423.0262.1692.6261.77
Short Term Debt 0.1560.1850.1370.7830.8410.9020.9530.9771.0581.1131.1951.3591.4440.7650.5820.6360.5540.5610.5380.2480.1630.1340.0670.0790.1020.248
Tax Payables 00000000000001.3511.9490.947000.1210000.0140.1030.0290.056
Deferred Revenue 0.5090.7630.4371.5480.3431.4580.351.8380.3412.2090.6130.3460.3440.2760.2910.2261.1311.1081.3030.8980.7770.7770.4280.4280.6340.645
Other Current Liabilities 1.0241.7335.13.0173.4354.8565.6024.145.1843.7763.2083.2481.6892.692.8192.2836.5181.5081.8211.7681.2641.10.860.7120.5930.067
Total Current Liabilities 2.9326.09210.42611.35610.12913.82712.52912.53711.11511.83410.79811.9228.9169.64710.1337.94512.82311.2759.3311.498.5996.0534.3823.3893.9552.731
Non-Current Liabilities:
Long Term Debt 16.6310.35116.6311.3811.5551.731.9142.1042.3412.5252.5093.0043.490.8810.7170.8080.6450.9171.2040.4270.3390.2790.2510.0270.0650.921
Deferred Revenue Non-Current 4.5054.4864.5845.9716.0875.8515.3234.9354.7014.224.5384.1393.1222.8642.7421.5447.5917.337.51910.48411.43910.77811.49512.07212.1480
Deferred Tax Liabilities Non-Current 0.9020.0130.118000-0.311.35818.3616.140.5431.53124.9120.1310.2040.2040.2040.20425.29100.1820-11.495-12.072-12.1480
Other Non-Current Liabilities 1.6390.2170.27113.78214.95314.89619.69816.8930.2650.37127.05423.621-0.00125.18722.57719.5921.7828.1950.02125.65137.850.18211.49512.07212.14811.406
Total Non-Current Liabilities 23.6775.06721.60421.13422.59522.47726.62525.2925.66723.25634.64432.29531.52329.06326.2422.14630.2236.64634.03536.56249.8111.23911.74512.09912.21312.328
Total Liabilities 26.60911.15932.0332.4932.72436.30439.15437.82736.78235.0945.44244.21740.43938.7136.37330.09143.04347.92143.36548.05258.40917.29216.12715.48816.16815.058
Equity:
Preferred Stock 00000000000000000000003.622000
Common Stock 32.94978.58578.58578.58578.58578.58554.95153.91350.12348.51348.51348.51341.55341.55341.55334.33733.13132.57132.57132.57132.5524.61524.57722.13816.4859.975
Retained Earnings -358.372-353.687-349.947-323.053-316.57-308.997-70.718-63.331-100.527-91.826-91.021-74.424-61.456-217.778-198.88-180.421-138.441-124.026-117.239-100.313-85.996-71.215-42.289-36.388-30.47-11.287
Accumulated Other Comprehensive Income/Loss 315.096269.804252.731268.801268.161267.73432.66832.06231.53530.95829.47728.18126.9625.66723.86323.32221.9524.32923.28621.20520.43719.982-3.622-1.8720.4290
Other Total Stockholders Equity 06.3176.3176.3176.3176.3172.1422.21744.18843.34943.34943.34933.862206.149206.148170.297160.611158.01158.01158.01157.89753.30253.38933.02112.4350
Total Shareholders Equity -10.3271.019-12.31430.6536.49343.63919.04324.86125.31930.99430.31845.61940.91955.59172.68447.53577.25190.88496.628111.473124.88826.68435.67716.898-1.122-1.312
Total Equity -10.3271.019-12.31430.6536.49343.63919.04324.86125.31930.99430.31845.61940.91955.59172.68447.53577.25190.88496.628111.473124.88826.68435.67716.898-1.122-1.312
Total Liabilities & Shareholders Equity 16.28212.17819.71663.1469.21779.94358.19762.68862.10166.08475.7689.83681.35894.301109.05777.626120.294138.805139.993159.525183.29743.97651.80432.38615.04613.746